Bio-Path Holdings Reports Fiscal Year 2014 Operational and Financial Results
Bio-Path Holdings reported operational and financial results for the year ended December 31, 2014. In a release on March 17, the Company noted that 2014 OPERATIONAL AND FINANCIAL HIGHLIGHTS include:. -In the fourth quarter of 2014, Bio-Path successfully completed Cohort 6 of its Phase 1 clinical trial evaluating its lead compound, Liposomal Grb-2, in blood…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Advisor News
- Investors remain skeptical of AI in financial advice
- House panel votes to raise certain taxes, transfer money to offset Medicaid shortfall
- OBBBA opens the door for advanced wealth transfer strategies
- Health insurance premium tax bill advancing
- The Medi-Cal money pit
More Advisor NewsAnnuity News
- Lincoln Financial launches two new FIAs
- Great-West Life & Annuity Insurance Company trademark request filed
- The forces shaping life and annuities in 2026
- Variable annuity sales surge as market confidence remains high, Wink finds
- New Allianz Life Annuity Offers Added Flexibility in Income Benefits
More Annuity NewsHealth/Employee Benefits News
- HAFA speaks out against Humana leader’s comments
- NABIP comments to CMS on proposed 2027 ACA marketplace rule
- U.S. House to hold hearing addressing rising health care costs this week
- Insurance firms warn against bill
- House panel votes to raise certain taxes, transfer money to offset Medicaid shortfall
More Health/Employee Benefits NewsLife Insurance News
- SBLI’s EasyTrak Term Now with Chronic Illness Rider at No Additional Premium Cost
- Ethics and IUL: Tax-advantaged strategies for client success
- SWBC’s Joan Cleveland Appointed to the Texas Life and Health Insurance Guaranty Association Board of Directors
- Indexed life sales hit big despite lawsuits, market headwinds, Wink finds
- Are the biggest life insurance opportunities hiding during tax season?
More Life Insurance News